Order Article Reprints

Kharouf N, Flanagan TW, Alamodi AA, Al Hmada Y, Hassan S-Y, Shalaby H, Santourlidis S, Hassan S-L, Haikel Y, Megahed M, et al. CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance. Cells. 2024; 13(3):240. https://doi.org/10.3390/cells13030240

Kharouf, Naji, Thomas W. Flanagan, Abdulhadi A. Alamodi, Youssef Al Hmada, Sofie-Yasmin Hassan, Hosam Shalaby, Simeon Santourlidis, Sarah-Lilly Hassan, Youssef Haikel, Mossad Megahed, and et al. 2024. "CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance" Cells 13, no. 3: 240. https://doi.org/10.3390/cells13030240

Kharouf, N., Flanagan, T. W., Alamodi, A. A., Al Hmada, Y., Hassan, S.-Y., Shalaby, H., Santourlidis, S., Hassan, S.-L., Haikel, Y., Megahed, M., Brodell, R. T., & Hassan, M. (2024). CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance. Cells, 13(3), 240. https://doi.org/10.3390/cells13030240